Literature DB >> 35019776

CT-based radiomics model for preoperative prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.

Sihang Cheng1,2, Xiang Yu2, Xinyue Chen3, Zhengyu Jin1, Huadan Xue1, Zhiwei Wang1, Ping Xie2.   

Abstract

OBJECTIVE: To develop and evaluate a machine learning-based CT radiomics model for the prediction of hepatic encephalopathy (HE) after transjugular intrahepatic portosystemic shunt (TIPS).
METHODS: A total of 106 patients who underwent TIPS placement were consecutively enrolled in this retrospective study. Regions of interest (ROIs) were drawn on unenhanced, arterial phase, and portal venous phase CT images, and radiomics features were extracted, respectively. A radiomics model was established to predict the occurrence of HE after TIPS by using random forest algorithm and 10-fold cross-validation. Receiver operating characteristic (ROC) curves were performed to validate the capability of the radiomics model and clinical model on the training, test and original data sets, respectively.
RESULTS: The radiomics model showed favorable discriminatory ability in the training cohort with an area under the curve (AUC) of 0.899 (95% CI, 0.848 to 0.951), while in the test cohort, it was confirmed with an AUC of 0.887 (95% CI, 0.760 to 1.00). After applying this model to original data set, it had an AUC of 0.955 (95% CI, 0.896 to 1.00). A clinical model was also built with an AUC of 0.649 (95% CI, 0.530 to 0.767) in the original data set, and a Delong test demonstrated its relative lower efficiency when compared with the radiomics model (p < 0.05).
CONCLUSION: Machine learning-based CT radiomics model performed better than traditional clinical parameter-based models in the prediction of post-TIPS HE. ADVANCES IN KNOWLEDGE: Radiomics model for the prediction of post-TIPS HE was built based on feature extraction from routine acquired pre-operative CT images and feature selection by random forest algorithm, which showed satisfied performance and proved the advantages of machine learning in this field.

Entities:  

Mesh:

Year:  2022        PMID: 35019776      PMCID: PMC9153699          DOI: 10.1259/bjr.20210792

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.629


  29 in total

1.  Texture analysis of the liver at MDCT for assessing hepatic fibrosis.

Authors:  Meghan G Lubner; Kyle Malecki; John Kloke; Balaji Ganeshan; Perry J Pickhardt
Journal:  Abdom Radiol (NY)       Date:  2017-08

2.  Early use of TIPS in patients with cirrhosis and variceal bleeding.

Authors:  Juan Carlos García-Pagán; Karel Caca; Christophe Bureau; Wim Laleman; Beate Appenrodt; Angelo Luca; Juan G Abraldes; Frederik Nevens; Jean Pierre Vinel; Joachim Mössner; Jaime Bosch
Journal:  N Engl J Med       Date:  2010-06-24       Impact factor: 91.245

3.  Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement.

Authors:  Silvia Nardelli; Barbara Lattanzi; Sabrina Torrisi; Francesca Greco; Alessio Farcomeni; Stefania Gioia; Manuela Merli; Oliviero Riggio
Journal:  Clin Gastroenterol Hepatol       Date:  2016-11-02       Impact factor: 11.382

Review 4.  Predictors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in cirrhotic patients: a systematic review.

Authors:  Ming Bai; Xingshun Qi; Zhiping Yang; Zhanxin Yin; Yongzhan Nie; Shanshan Yuan; Kaichun Wu; Guohong Han; Daiming Fan
Journal:  J Gastroenterol Hepatol       Date:  2011-06       Impact factor: 4.029

5.  Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study.

Authors:  O Riggio; A Masini; C Efrati; F Nicolao; S Angeloni; Filippo M Salvatori; M Bezzi; Adolfo F Attili; M Merli
Journal:  J Hepatol       Date:  2005-05       Impact factor: 25.083

6.  Observational cohort study of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS).

Authors:  Michaela Routhu; Vaclav Safka; Sunil Kumar Routhu; Tomas Fejfar; Vaclav Jirkovsky; Antonin Krajina; Eva Cermakova; Ladislav Hosak; Petr Hulek
Journal:  Ann Hepatol       Date:  2017 Jan-Feb       Impact factor: 2.400

7.  Raised serum Interleukin-6 identifies patients with liver cirrhosis at high risk for overt hepatic encephalopathy.

Authors:  Christian Labenz; Gerrit Toenges; Yvonne Huber; Michael Nagel; Jens U Marquardt; Jörn M Schattenberg; Peter R Galle; Joachim Labenz; Marcus-Alexander Wörns
Journal:  Aliment Pharmacol Ther       Date:  2019-10-03       Impact factor: 8.171

8.  Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts.

Authors:  Oliviero Riggio; Stefania Angeloni; Filippo Maria Salvatori; Adriano De Santis; Federica Cerini; Alessio Farcomeni; Adolfo Francesco Attili; Manuela Merli
Journal:  Am J Gastroenterol       Date:  2008-09-04       Impact factor: 10.864

9.  Radiomics: Images Are More than Pictures, They Are Data.

Authors:  Robert J Gillies; Paul E Kinahan; Hedvig Hricak
Journal:  Radiology       Date:  2015-11-18       Impact factor: 11.105

Review 10.  Hepatic Encephalopathy: Definition, Clinical Grading and Diagnostic Principles.

Authors:  Karin Weissenborn
Journal:  Drugs       Date:  2019-02       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.